Blood Transfusion Diagnostics Market - Top Companies and Manufacturers

Companies Dominating the Blood Transfusion Diagnostics Landscape

Immucor, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Bio-Rad Laboratories, Inc.
Danaher Corporation
Quotient Limited
Beckman Coulter, Inc.
DiaSorin S.p.A.
BD (Becton, Dickinson, and Company)
Ortho Clinical Diagnostics
Grifols, S.A.
Thermo Fisher Scientific Inc.

Browse Key Market Insights with Data Illustration:

Blood Transfusion Diagnostics Market Size & Share, Forecast Report 2033

In the News

Danaher Corporation announced the acquisition of Aldervon. Aldervon was the only operating company within Danaher’s Life Sciences segment.
Grifols S.A. announced the acquisition of Biotest to boost the development and innovation of its product portfolio, increasing the availability of plasma therapy for patients.

Frequently Asked Questions (FAQ)

Growing cases of COVID-19, rising road accidents, a dearth of blood donations, and a higher number suffering from kidney issues and chronic disease are the few factors likely to propel the market growth.

The market is anticipated to attain a CAGR of 4% over the forecast period, i.e., 2023-2033.

The dearth of skilled technicians, exorbitant prices of tests and instruments, and shortage of infrastructure are the few factors that are likely to hamper the market growth.

The market in the North American region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Immucor, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Quotient Limited, Beckman Coulter, Inc., DiaSorin S.p.A., BD (Becton, Dickinson, and Company), Ortho Clinical Diagnostics, Grifols, S.A., Thermo Fisher Scientific Inc., and so onâ€¦

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, application, end-user, and by region.

Blood screening is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Blood Transfusion Diagnostics Market - Top Companies and Manufacturers

Companies Dominating the Blood Transfusion Diagnostics Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the blood transfusion diagnostics market?

What would be the CAGR of blood transfusion diagnostics market over the forecast period?

What are the challenges affecting the blood transfusion diagnostics market growth?

Which region will provide more business opportunities for growth of blood transfusion diagnostics market in future?

Who are the major players dominating the blood transfusion diagnostics market?

How are the company profiles selected?

What are the segments in the blood transfusion diagnostics market?

Which segment captures the largest market size in application in the blood transfusion diagnostics market?